Aurinia Pharmaceuticals Inc.

Ticker: AUPH

Class Period Start: 05/07/2021

Class Period End: 02/25/2022

Registration Deadline: 06/14/2022

A class action lawsuit has been filed on behalf of purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7, 2021 and February 25, 2022.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:

  • Aurinia was experiencing declining revenues;
  • Aurinia’s 2022 sales outlook for LUPKYNIS would fall well short of expectations;
  • accordingly, the Company had significantly overstated LUPKYNIS’s commercial prospects;
  • as a result, the Company had overstated its financial position and/or prospects for 2022; and
  • as a result, the Company’s public statements were materially false and misleading at all relevant times.

If you suffered a loss on your investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Purchases

Sales

Please Note

Neither the submission to nor the receipt of information by Lowey Dannenberg or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* Indicates a required field.

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.